The UK OFT recommends to replace the Pharmaceutical Price Regulation Scheme by ex-ante pricing

1. Introduction The OFT's market study on the Pharmaceutical Price Regulation Scheme (PPRS) has recommended that the government introduce an ex-ante based pricing system to replace the current PPRS. It fully acknowledges that its pro-innovation approach could create a market of “winners and losers” that is favourable to those that chose to innovate and hostile to those that don't. It acknowledges that a truly pro-innovative system may not necessarily work in harmony with untrammelled parallel trade and considers how the two could ever exist side by side in this particular industry. If accepted by the Government, could it revolutionise the way in which medicines are priced? The report was published on 20 February 2007. In it the OFT recommends that the current regime of profit controls

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Rachael Mooney, The UK OFT recommends to replace the Pharmaceutical Price Regulation Scheme by ex-ante pricing, 21 February 2007, e-Competitions Bulletin February 2007, Art. N° 13343

Visites 6732

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues